NIH To Test Effectiveness Of Experimental Male Contraceptive Topical Gel

ABC News: This male birth control comes as a topical gel and will be tested in a clinical trial
“The National Institutes of Health recently funded a study to see if a topical gel for men could prevent pregnancy, potentially giving couples who don’t want children a new contraceptive option…” (Strauss, 11/28).

Bloomberg: A Male Birth Control Gel Is Getting Closer to Reality
“…The study is being conducted by the National Institutes of Health and will involve 420 couples. The experimental treatment is a gel, applied to the back and shoulders, that combines two types of hormones to halt the production of sperm while maintaining the energy and libido benefits of testosterone…” (Cortez, 11/28).

NBC News: Birth control for men: researchers test a male contraceptive gel
“…The gel formulation, called NES/T, includes a progestin-containing compound called segesterone acetate, which is made under the brand name Nestorone, along with a dose of testosterone…” (Fox, 11/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.